Why UK Patients Compare These Two Leading Treatments
Wegovy Doses UK vs Mounjaro: The Complete Dosing Comparison
Understanding Wegovy doses UK compared to Mounjaro requires examining two distinct escalation schedules designed for different patient needs. Wegovy follows a 5-dose progression: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This semaglutide-based approach allows gradual adaptation to the GLP-1 receptor agonist effects. Mounjaro uses a 6-dose schedule starting higher at 2.5mg, progressing through 5mg, 7.5mg, 10mg, 12.5mg, to 15mg maintenance, reflecting tirzepatide's dual GIP and GLP-1 receptor targeting mechanism.
The fundamental difference lies in their mechanisms: Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro activates both GIP and GLP-1 pathways. This explains why Wegovy doses UK start lower at 0.25mg compared to Mounjaro's 2.5mg starting dose. Both prescription-only medicines require mandatory dose escalation - you cannot skip doses or start at maintenance levels. EverydayMeds stocks complete dose ranges for both treatments, ensuring seamless progression through your prescribed escalation schedule.
Wegovy Doses UK Pricing vs Mounjaro Cost Analysis
EverydayMeds offers transparent pricing for all Wegovy doses UK with discount codes applied at checkout. Single pens start at £79.99 for 0.25mg starter dose (with FIRST40 for new customers), progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for 2.4mg maintenance. Our Getting Started Bundles provide convenient dose transitions: Intro Duo (0.25mg & 0.5mg) for £169.99, or Progress Duo (0.5mg & 1mg) for £189.99. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ideal for established patients.
Mounjaro pricing follows a different structure reflecting its unique dual-receptor mechanism and higher dose requirements. Returning customers benefit from DOSE25 discount code, whilst new patients use FIRST40 - both applied automatically at checkout to reach our advertised prices. The key advantage of choosing EverydayMeds for your Wegovy doses UK comparison is accessing both treatments through one clinical assessment, avoiding multiple pharmacy relationships and ensuring consistent cold-chain delivery standards.
Clinical Evidence: Wegovy Doses UK Performance vs Mounjaro Trials
Wegovy's clinical evidence comes primarily from the STEP trial programme, where patients taking prescribed Wegovy doses UK alongside diet and exercise achieved significant weight management outcomes. In STEP 1, participants experienced approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained clinically studied weight loss maintained over two years with continued treatment.
Mounjaro's evidence base stems from the SURMOUNT trials, though direct comparison between trial results isn't appropriate due to different study designs and patient populations. Both treatments demonstrated cardiovascular benefits in their respective trials, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. Your prescriber will consider your individual clinical profile when recommending between Wegovy doses UK and Mounjaro options.
How Wegovy Doses UK Work: Understanding the GLP-1 Mechanism
Wegovy doses UK work by mimicking GLP-1, a natural hormone that regulates appetite and blood sugar levels. When you inject your prescribed Wegovy dose, semaglutide binds to GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings. This mechanism explains why the dose escalation schedule is crucial - your body needs time to adapt to increasing GLP-1 receptor activation. The weekly injection using Novo Nordisk's FlexTouch pen delivers consistent medication levels, supporting appetite control throughout the week. Unlike Mounjaro's dual GIP+GLP-1 approach, Wegovy focuses exclusively on GLP-1 pathways, which some patients find easier to tolerate during dose escalation.
Ordering Wegovy Doses UK Through EverydayMeds
Accessing Wegovy doses UK through EverydayMeds begins with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining whether Wegovy, Mounjaro, or alternative treatments suit your needs. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication stability. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and pharmaceutical-grade storage standards. You'll receive injection training materials and ongoing clinical support throughout your treatment journey.
Storage Advantages: Wegovy Doses UK vs Mounjaro Practicalities
Wegovy doses UK offer significant storage advantages over Mounjaro, particularly for frequent travelers or those with limited refrigerator space. Unused Wegovy pens must be stored at 2-8°C, but once removed from refrigeration, they remain stable for 6 weeks at room temperature below 30°C. This compares favorably to Mounjaro's 21-day room temperature limit, giving Wegovy users nearly three times longer flexibility for travel or storage emergencies. Both treatments use pre-filled injection pens - Wegovy's FlexTouch system from Novo Nordisk and Mounjaro's KwikPen from Eli Lilly. The injection technique is similar, but some patients prefer one pen design over the other based on grip comfort and dose selection ease.
Wegovy Doses UK vs Mounjaro: Side Effect Profiles and Tolerance
Both Wegovy doses UK and Mounjaro share similar gastrointestinal side effects due to their action on GLP-1 receptors, including nausea, vomiting, and diarrhea, typically most pronounced during dose escalation phases. However, the different escalation schedules mean side effect timing varies between treatments. Wegovy's gentler starting dose of 0.25mg may suit patients sensitive to initial GLP-1 effects, whilst Mounjaro's 2.5mg starting dose reflects its dual-receptor mechanism requiring higher initial dosing.
The key difference lies in Mounjaro's additional GIP receptor activation, which some patients find affects blood sugar levels differently than Wegovy's GLP-1-only approach. Your prescriber will consider your medical history, including any diabetes or cardiovascular conditions, when choosing between Wegovy doses UK and Mounjaro. Both treatments are subject to MHRA additional monitoring (Black Triangle ▼), ensuring ongoing safety surveillance.
Making the Choice: Wegovy Doses UK or Mounjaro for Your Goals
Choosing between Wegovy doses UK and Mounjaro depends on multiple factors beyond pricing, including your medical history, lifestyle preferences, and tolerance for different mechanisms of action. EverydayMeds' unique position of supplying both treatments means your prescriber can recommend the most suitable option without commercial bias. Some patients prefer Wegovy's proven single-receptor approach and gentler dose escalation, whilst others benefit from Mounjaro's dual-pathway mechanism. The 6-week room temperature storage advantage of Wegovy doses UK may influence frequent travelers, whilst Mounjaro's different dose timing might suit alternative injection schedules. Remember that both treatments require long-term commitment - weight management is an ongoing process requiring consistent medication adherence alongside lifestyle modifications. Your EverydayMeds prescriber will help determine which treatment aligns best with your individual circumstances and weight management objectives.
Start your weight management journey today with expert clinical assessment and access to both leading treatments. Use discount code FIRST40 for new customers or DOSE25 for returning patients at checkout. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which treatment suits your needs. Our experienced clinical team provides ongoing support throughout your journey, ensuring you achieve sustainable weight management results with the most appropriate prescription-only medicine for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
